Eculizumab: 5G1.1, h5G1.1, Long-Acting Anti-C5 Monoclonal Antibody 5G1-1, Long-Acting Anti-C5 Monoclonal Antibody 5G1.1

ISSN： 1174-5886

Source： Drugs in R&D, Vol.8, Iss.1, 2007-01, pp. : 61-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The anti-HIV-1 monoclonal antibodies 2F5 and 2G12 are well tolerated

Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody

By Smith Deborah A.

Clinical Pharmacokinetics, Vol. 50, Iss. 4, 2011-04 ,pp. : 215-227

Adis International

Access to resources Recommend Favorite

Mepolizumab: 240563, Anti-IL-5 Monoclonal Antibody - GlaxoSmithKline, Anti-Interleukin-5 Monoclonal Antibody - GlaxoSmithKline, SB 240563

By Adis International Limited

Drugs in R&D, Vol. 9, Iss. 2, 2008-01 ,pp. : 125-130

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of mepolizumab, an anti–interleukin 5 monoclonal antibody, in healthy Japanese male subjects

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 102-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT 1 receptor antagonist

By Aiyar N. Baker E. Vickery-Clark L. Ohlstein E.H. Gellai M. Fredrickson T.A. Brooks D.P. Weinstock J. Weidley E.F. Edwards R.M.

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 63-72

Elsevier

Access to resources Recommend Favorite